- Report
- August 2023
- 78 Pages
Egypt
From €3384EUR$3,500USD£2,906GBP
- Report
- June 2021
- 120 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- February 2019
- 84 Pages
Global
From €3142EUR$3,250USD£2,699GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- March 2022
- 120 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- October 2021
- 120 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- January 2023
- 96 Pages
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- January 2023
- 94 Pages
Middle East, Africa
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- January 2023
- 104 Pages
North America
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- January 2023
- 111 Pages
Asia Pacific
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- October 2022
- 159 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- April 2020
- 156 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- April 2023
- 80 Pages
South Korea
From €4592EUR$4,750USD£3,945GBP
- Report
- April 2023
- 75 Pages
South Africa
From €4592EUR$4,750USD£3,945GBP
- Report
- April 2023
- 111 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- June 2022
- 115 Pages
Global
From €4592EUR$4,750USD£3,945GBP
The Ventricular Assist Device (VAD) market is a subset of the Cardiovascular Devices market. VADs are mechanical pumps that are implanted in the body to help the heart pump blood. They are used to treat heart failure, bridge patients to heart transplantation, and provide long-term support for patients with end-stage heart failure. VADs are typically used in patients who are not eligible for heart transplantation or who are waiting for a donor heart.
VADs are classified into two main categories: left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs). LVADs are used to support the left ventricle, while RVADs are used to support the right ventricle. Both types of VADs are designed to improve the quality of life of patients with heart failure.
Some companies in the VAD market include Abiomed, Medtronic, Thoratec, and SynCardia. Show Less Read more